Precedence Research, Recently Published Report on “Life Science Tools Market Size, Share, Growth, Trends, Segment Forecasts, Regional Outlook 2020 - 2027”. The report offers an up-to-date analysis regarding the current market scenario, latest trends, key drivers, potential challenges, profitability graph and the overall market environment.
The global Life Science Tools Market value is projected to reach US Dollar 95.68 billion by 2027 and is projected to expand at a CAGR of ~8.5%% from 2020 to 2027.
Introduction
Life science is a branch of science that deals with the study of microorganisms and organisms. It is an umbrella term for wide range of fields such as biotechnology, biomedicine, cell biology, molecular biology, genetics, and biochemistry. The global life sciences tools market includes reagents, consumables, instruments, and various other services. The growth of the healthcare industry, pharmaceutical industry, and the prominent rise in the research and development sector has significantly augmented the global life sciences tools market growth in the recent years.
Growth Factors
The availability of better instruments and improved reagents has speed up the research and development process of drug. Rising investments in the development of bleeding edge technologies that improves life science instruments expected to trigger the growth of life science tools during the analysis period. In addition, prevalence of cancer and other major diseases also fuel the need for genomic analysis to early diagnose and cure the disease. Increasing cases of genetic disorder and birth defects have also prominently triggers the demand for life science tools in the near future. World Health Organization (WHO) has also quoted that prevalence of single gene disease at the time of birth is approximately 10 out of 1000 across the world.
Get the Sample Pages of Report for More Undestanding@ https://www.precedenceresearch.com/sample/1064
Report Highlights
- In 2019, North America accounted for the maximum revenue share in 2019 due to local presence of major market leaders such as Thermo Fisher Scientific. Reputable informatics network along with well-regulated framework for approval and usage of genomic tests in the region again propel the growth of market.
- The Asia Pacific poised to witness the fastest growth during the analysis period. This is attributed to the increasing penetration of leading market players in emerging Asian countries and rising investments for design of advanced diagnostic methods.
- Cell biology technology dominated the global life science tools market in 2019 and followed by genomics technology in terms of revenue share. Besides this, proteomics application segment projected to register the highest growth over the forecast period. This is attributed to complete illustration provided by the proteome analysis related to structural and functional information of the cell as well as their response mechanisms against drugs and other outside factors.
- Based on product, separation technologies accounted for the major market value share in 2019. However, nucleic acid microarray segment predicted to register the fastest growth over the forecast period.
- The healthcare segment occupied maximum market value share in 2019 and expected to witness substantial growth over the forecast period. Rising adoption of proteomic and genomic workflow in hospitals to treat and diagnose various clinical abnormalities analyzed to fuel the market growth. However, biopharmaceutical companies expected to grow at a lucrative CAGR during the forecast period. These companies have initiated large number of genome sequencing projects by collaborating with academic medical centers and community health systems that account for its significant growth during the forecast period.
Buy this Premium Research Report, Click Here@ https://www.precedenceresearch.com/checkout/1064
Regional Snapshots
North America led the global life science tools market with significant revenue share in 2019 due to prominent presence of major market leaders such as Thermo Fisher Scientific. Increasing investment for research & development in medical science contribute significantly for the market growth. In addition, the region is technologically advanced in terms of healthcare facilities as well as invests significantly on the development of hospitals and other medical centers that augment the growth of life science tools in the coming years.
On the other hand, the Asia Pacific seeks lucrative growth over the forecast period due to increasing expenditure on treatment coupled with emergence of the healthcare sector in the region projected to propel the growth of life science tools in the region.
Key Players & Strategies
The global life science tools market is dominated by the major market leaders such as Thermo Fisher Scientific and AgilentTechnologies. Thermo Fisher Scientific is among the largest suppliers of wide range of innovative solutions for life science tools and other solutions across the globe. Similarly, AgilentTechnologies is one of the market leaders in chromatography market that has strong foothold in the gas chromatography and high-performance liquid chromatography markets. Furthermore, biopharmaceutical companies are significantly collaborating and entering into partnership with medical research centers and health institutes to escalate the development of genomic science.
Some of the key players operating in the market are Agilent Technologies; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories, Inc.; Bruker Corporation; Danaher Corporation; GE Healthcare; Hitachi, Ltd.; Illumina, Inc.; Merck KGaA; Oxford Instruments plc; Qiagen N.V.; Shimadzu Corporation; Thermo Fisher Scientific, Inc.; and ZEISS International among others.
Market Segmentation
By Technology
- Genomic Technology
- Cell Biology Technology
- Proteomics Technology
- Lab Supplies & Technologies
- Other Analytical & Sample Preparation Technology
By Product
- NGS
- Sanger Sequencing
- Nucleic Acid Preparation
- Nucleic Acid Microarray
- PCR & qPCR
- Flow Cytometry
- Mass Spectrometry
- Separation Technologies
- Electron Microscopy
- NMR
- Others
By End-User
- Biopharmaceutical Company
- Government & Academic
- Industry
- Health Care
- Others
By Regional Outlook
- North America
- Europe
- Asia Pacific
- Rest of the World
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Technology Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Life Science Tools Market, By Product
7.1. Life Science Tools Market, by Product Type, 2020-2027
7.1.1. NGS
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Sanger Sequencing
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Nucleic Acid Preparation
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Nucleic Acid Microarray
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. PCR & qPCR
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Flow Cytometry
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Mass Spectrometry
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Separation Technologies
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Electron Microscopy
7.1.9.1. Market Revenue and Forecast (2016-2027)
7.1.10. NMR
7.1.10.1. Market Revenue and Forecast (2016-2027)
7.1.11. Others
7.1.11.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Life Science Tools Market, By End-User
8.1. Life Science Tools Market, by End-User, 2020-2027
8.1.1. Biopharmaceutical Company
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Government & Academic
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Industry
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Health Care
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Life Science Tools Market, By Technology
9.1. Life Science Tools Market, by Technology, 2020-2027
9.1.1. Genomic Technology
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Cell Biology Technology
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Proteomics Technology
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Lab Supplies & Technologies
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Other Analytical & Sample Preparation Technology
9.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Life Science Tools Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Technology (2016-2027)
Chapter 11. Company Profiles
11.1. Agilent Technologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hoffmann-La Roche Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-Rad Laboratories, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bruker Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hitachi, Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Illumina, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Oxford Instruments plc
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Qiagen N.V.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Shimadzu Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Thermo Fisher Scientific, Inc.
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. ZEISS International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1064
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 774 402 6168
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
0 Comments